Published November 20, 2023 | Version v1
Book chapter Restricted

System licencjonowania przymusowego na eksport w TRIPS – teoria a praktyka

Authors/Creators

Description

This article aims to present the system of compulsory licensing resulting from the TRIPS Agreement, with particular emphasis on the impact of the Doha Declaration of 2001 and the Geneva Declaration of 2022. The principles of compulsory licensing contained in art. 31 of the Agreement and the possibility of exemptions from some of them thanks to the Doha Declaration, as well as the proposed changes in their application resulting from the Geneva Declaration was indicated. In addition, the case of granting a compulsory license in the territory of Canada in the interest of Rwanda was mentioned, which was the first and so far the last example of using the TRIPS compulsory licensing system in practice. The analysis of the above issues makes it possible to determine whether the described system is properly regulated or whether it requires further work and modifications.

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Additional details

Additional titles

Alternative title (English)
Compulsory licensing for export in TRIPS – theory and practice

Related works

Is part of
Book chapter: 978-83-66300-82-8 (ISBN)

References

  • Konwencja związkowa paryska z dnia 20 marca 1883 r. o ochronie własności przemysłowej, przejrzana w Brukseli dnia 14 grudnia 1900 roku, w Waszyngtonie dnia 2 czerwca 1911 r. i w Hadze dnia 6 listopada 1925 r. (ratyfikowana zgodnie z ustawą z dnia 17 marca 1931 r.), Dz.U. 1932 Nr 2, poz. 8.
  • Konwencja berneńska o ochronie dzieł literackich i artystycznych z dnia 9 września 1886 r., przejrzana w Berlinie dnia 13 listopada 1908 r. i w Rzymie dnia 2 czerwca 1928 r. (ratyfikowana zgodnie z ustawą z dnia 5 marca 1934 r.), Dz.U. 1935 Nr 84, poz. 515.
  • Ustawa z dnia 4 lutego 1994 r. o prawie autorskim i prawach pokrewnych, t.j. Dz.U. 2022, poz. 2509.
  • Porozumienie ustanawiające Światową Organizację Handlu (WTO), sporządzone w Marakeszu dnia 15 kwietnia 1994 r., Dz.U. 1995 Nr 98, poz. 483.
  • Porozumienie w sprawie handlowych aspektów praw własności intelektualnej, Marakesz 23 grudnia 1994 r., Dz. Urz. UE L 336 z 23.12.1994, s. 214.
  • Council for Trade-Related Aspects of Intellectual Property Rights – Notification under the amended TRIPS Agreement – Notification of intention to use the special compulsory licensing system as an importing Member – Antigua and Barbuda, https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S006. aspx?Query=(%20@Symbol=%20ip/n/8/*%20anguage=ENGLISH&Context= FomerScriptedSearch&languageUIChanged=true# [dostęp: 26.01.2023].
  • Declaration on the TRIPS agreement and public health. Adopted on 14 November 2001, https://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm [dostęp: 26.01.2023].
  • Implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health, Decision of the General Council of 30 August 2003, https://www. wto.org/english/tratop_e/trips_e/implem_para6_e.htm [dostęp: 26.01.2023].
  • Notification under Paragraph 2(c) of the Decision of 30 August 2003 on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health. Canada, IP/N/10/CAN/1, https://docs.wto.org/dol2fe/ Pages/SS/directdoc.aspx?filename=Q:/IP/N/10CAN1.pdf&Open=True [dostęp: 26.01.2023].
  • Notification under Paragraph 2(A) of the Decision of 30 August 2003 on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement And Public Health. Rwanda, IP/N/9/RWA/1 https://docs.wto.org/dol2fe/ Pages/SS/directdoc.aspx?filename=Q:/IP/N/9RWA1.pdf&Open=True [dostęp: 26.01.2023].
  • Ministerial Declaration on the WTO Response to the COVID-19 Pandemic and Preparedness for Future Pandemics Adopted on 17 June 2022, https://docs.wto.org/ dol2fe/Pages/SS/directdoc.aspx?filename=q:/WT/MIN22/31.pdf&Open=True [dostęp: 26.01.2023].
  • Amendment of the TRIPS Agreement. Decision of 6 December 2005, https://www.wto. org/english/tratop_e/trips_e/wtl641_e.htm [dostęp: 26.01.2023].
  • Summary of the meeting of the Committee on International Trade (INTA) Brussels, 4–5 June 2007, http://register.consilium.europa.eu/doc/srv?l=EN&f=ST%2010503%20 2007%20INIT [dostęp: 26.01.2023].
  • Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19, Communication from India and South Africa, IP/C/W/669, https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=q:/ IP/C/W669.pdf&Open=True [dostęp: 26.01.2023].
  • WHO Director-General's opening remarks at the media briefing on COVID-19 11 March 2020, https://www.who.int/director-general/speeches/detail/who-director-generals- opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 [dostęp: 26.01.2023].
  • Abbas M.Z., Pros and cons of compulsory licensing: An analysis of arguments, "International Journal of Social Science and Humanity" 2013, nr 3(3), s. 254–258, http://www. ijssh.org/papers/239-D00013.pdf [dostęp: 28.08.2023].
  • Abbott F.M., Reichman J.H., The Doha Round's public health legacy: strategies for the production and diffusion of patented medicines under the amended TRIPS provisions, "Journal of International Economic Law" 2007, nr 10(4), s. 936–945.
  • Correa C.M., Intellectual Property Rights, the WTO and Developing Countries. The TRIPS Agreement and Policy Options, Zed Books, Londyn, Nowy Jork 2000, https://books. google.pl/books?id=tV6tzmkghGUC&pg=PP7&hl=pl&source=gbs_selected_ pages&cad=2#v=onepage&q&f=false [dostęp: 28.08.2023].
  • Correa C.M., Syam N., The WTO TRIPS decision on COVID-19 vaccines: What is needed to implement it?, "South Center Research Paper" 2022, nr 169, https:// www.southcentre.int/wp-content/uploads/2022/11/RP169_The-WTO-TRIPSDecision-on-COVID-19-Vaccines_EN.pdf [dostęp: 30.08.2023].
  • Hutchison C., Does TRIPS facilitate or impede climate change technology transfer into developing countries?, "University of Ottawa Law & Technology Journal" 2006, t. 3, s. 517–537, https://ssrn.com/abstract=1019365 [dostęp: 28.08.2023].
  • Love J.P., Recent examples of the use of compulsory licences on patents, "Knowledge Ecology International Research Note" 2007, nr 2, http://www.keionline.org/misc-docs/ recent_cls_8mar07.pdf [dostęp: 20.01.2023].
  • Mercurio B., Upreti P., From necessity to flexibility: A reflection on the negotiations for a TRIPS waiver for COVID-19 vaccines and treatments, "World Trade Review" 2022, nr 5(21), s. 633–649 https://doi.org/10.1017/S1474745622000283.
  • Mogens P.C., Evaluating the TRIPS negotiations: a plea for a substantial review of the Agreement, [w :] J. Watal, A. Taubman (red.), The Making of the TRIPS Agreement. Personal insights from the Uruguay Round negotiations, WTO, Genewa 2015, https:// doi.org/10.30875/116e56b2-en.
  • Omino M., Kahumbu J., Left on our own: COVID-19, TRIPS- Plus Free Trade Agreements, and the Doha Declaration on TRIPS and public health, "South Center Research Paper" 2022, nr 170, s. 16–18; https://www.europarl.europa.eu/RegData/etudes/ ATAG/2021/690649/EPRS_ATA(2021)690649_EN.pdf [dostęp: 26.01.2023];
  • Otten A., The TRIPS negotiations: An overview [w:] J. Watal, A. Taubman (red.), The Making of the TRIPS Agreement. Personal Insights from the Uruguay Round Negotiations, WTO, Genewa 2015, s. 55–78, https://doi.org/10.30875/f81288c0-en.
  • Remuneration guidelines for non-voluntary use of a patent on medical technologies, "Health Economics and Drugs", TCM Series, nr 18, WTO, Waszyngton 2005, https:// apps.who.int/iris/bitstream/handle/10665/69199/WHO_TCM_2005.1_eng. pdf?sequence=1&isAllowed=y [dostęp: 20.01.2023].
  • Taubman A., Thematic review: Negotiating "trade- related aspects" of intellectual property rights, [w:] J. Watal, A. Taubman (red.), The Making of the TRIPS Agreement. Personal Insights from the Uruguay Round Negotiations, WTO, Genewa 2015, s. 15–52, https://doi.org/10.30875/00344762-en.
  • Canadian-made Drugs for Rwanda: The First Application of the WTO Waiver on Patents and Medicines, https://www.asil.org/insights/volume/11/issue/28/canadian-made- drugs-rwanda-first-application-wto-waiver-patents-and [dostęp: 26.01.2023].
  • Green A., WTO finally agrees on a TRIPS deal. But not everyone is happy, https:// www.devex.com/news/wto-finally-agrees-on-a-trips-deal-but-not-everyone-ishappy- 103476 [dostęp: 26.01.2023].
  • Members continue discussion on TRIPS Decision extension to therapeutics and diagnostics, https://www.wto.org/english/news_e/news23_e/heal_17mar23_e. htm [dostęp: 20.03.2023].
  • Półprzewodniki, [w:] Encyklopedia PWN, https://encyklopedia.pwn.pl/haslo/ polprzewodniki;3961550.html [dostęp: 20.01.2023].
  • TRIPS 'Waiver failure': EU betrayal of global south on vaccine access obscured by lack of transparency, https://corporateeurope.org/en/2022/07/trips-waiver-failure-eubetrayal- global-south-vaccine-access-obscured-lack-transparency [dostęp: 26.01.2023].